Page last updated: 2024-08-24

valsartan and Genetic Predisposition

valsartan has been researched along with Genetic Predisposition in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Axelsson Raja, A; Bach, RG; Becker, JR; Benson, L; Bundgaard, H; Canter, C; Cirino, AL; Colan, SD; Day, SM; Ho, CY; Lakdawala, NK; Lever, HM; MacRae, CA; Margossian, R; McMurray, JJV; Mestroni, L; Murphy, AM; Orav, EJ; Owens, AT; Patel, AR; Pereira, AC; Rossano, JW; Russell, MW; Seidman, CE; Solomon, SD; Soslow, JH; Taylor, MRG; Thrush, P; Vissing, CR; Wheeler, MT; Wilmot, I; Zahka, K1
Ahmed, A; Banach, M; Bielecka-Dabrowa, A; Misztal, M; Pietrucha, T; Rysz, J; Sakowicz, A; von Haehling, S1
Peng, W; Qiao, H; Wang, L; Wang, Y; Wu, C; Xu, Z; Zhang, X1
Wang, YP; Wang, YY; Xiao, ZX; Zhang, QY; Zhao, C1
Barclay, BW; Navarrete, AE; Sahota, P; Webb, RL; Wosu, NJ1

Trials

2 trial(s) available for valsartan and Genetic Predisposition

ArticleYear
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
    JAMA cardiology, 2023, 11-01, Volume: 8, Issue:11

    Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Child; Female; Genetic Predisposition to Disease; Humans; Hypertrophy, Left Ventricular; Male; Valsartan; Ventricular Remodeling

2023
[The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].
    Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2007, Volume: 24, Issue:4

    Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Female; Genetic Predisposition to Disease; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Genetic; Tetrazoles; Time Factors; Transforming Growth Factor beta1; Treatment Outcome; Valine; Valsartan

2007

Other Studies

3 other study(ies) available for valsartan and Genetic Predisposition

ArticleYear
Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
    International journal of cardiology, 2016, Oct-15, Volume: 221

    Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cardiomyopathy, Dilated; Drug Combinations; Female; Genetic Markers; Genetic Predisposition to Disease; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Nitric Oxide Synthase Type III; Polymorphism, Single Nucleotide; Stroke Volume; Syndecan-4; Tetrazoles; Transforming Growth Factor beta1; Valsartan

2016
The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2016, Volume: 17, Issue:3

    Topics: Diabetic Nephropathies; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Protective Agents; Valsartan

2016
Protective effects of valsartan and benazeprilat in salt-loaded stroke-prone spontaneously hypertensive rats.
    Clinical and experimental hypertension (New York, N.Y. : 1993), 1998, Volume: 20, Issue:7

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Cerebrovascular Disorders; Genetic Predisposition to Disease; Heart Rate; Hypertension; Infusion Pumps; Kidney; Myocardium; Proteinuria; Rats; Rats, Inbred SHR; Renin; Renin-Angiotensin System; Sodium Chloride; Tetrazoles; Valine; Valsartan

1998